Talk:Clobetasol propionate

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Clobetasol propionate.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

INN

In accordance with Wikipedia:WikiProject_Drugs naming policy, I propose we move this page to the INN clobetasol. If you have any concern with this proposal, please discuss it on this page. Matt 23:56, 21 Dec 2004 (UTC)

I have no problem with the move.--AAAAA 01:11, 24 Dec 2004 (UTC)

It can be included that in Brazil, this drug is sold under the name Therapsor. --Diogo (talk) 03:00, 16 August 2010 (UTC)[reply]

This is a different formulation with preparations (e.g., gel, foam, shampoo, etc). More importantly, it has different indications.

I suggest we delete this comment and keep article as-is: do not merge. thnx! Gobucks821 (talk) 16:58, 3 August 2024 (UTC)[reply]

Copyright problem removed

Prior content in this article duplicated one or more previously published sources. The material was copied from: Physicians Desk Reference 2006. Infringing material has been rewritten or removed and must not be restored, unless it is duly released under a compatible license. (For more information, please see "using copyrighted works from others" if you are not the copyright holder of this material, or "donating copyrighted materials" if you are.) For legal reasons, we cannot accept copyrighted text or images borrowed from other web sites or published material; such additions will be deleted. Contributors may use copyrighted publications as a source of information, but not as a source of sentences or phrases. Accordingly, the material may be rewritten, but only if it does not infringe on the copyright of the original or plagiarize from that source. Please see our guideline on non-free text for how to properly implement limited quotations of copyrighted text. Wikipedia takes copyright violations very seriously, and persistent violators will be blocked from editing. While we appreciate contributions, we must require all contributors to understand and comply with these policies. Thank you. Moonriddengirl ^(talk) 14:16, 24 March 2012 (UTC)[reply]

Cushing's Syndrome? Really?

Is C.S. really a likely side-effect from topical use of a steroidal ointment? DavidFarmbrough (talk) 05:08, 22 June 2012 (UTC)[reply]

You know the way such lists are generated. The manufacturer has to list any adverse reactions or complications that the FDA study group(s) indicated might have been connected to use of the drug. If a single person was diagnosed with CS in such a study, it's possible that the incident will make its way on to "list of possible side effects," even though the likelihood that the drug had anything to do with it is often negligible. While ostensibly used to monitor safety and provide information to physicians and patients, it also provides legal cover for the manufacturer. Redness, itching, hair loss; sure, makes sense. Neurological disorders? Probably not. But that's the way the system has evolved. 124.33.208.179 (talk) 03:01, 3 November 2013 (UTC)[reply]

Moved from article

I have moved the following content here because it lacks context/explanation. If anyone wants to use it to improve the article, here it is. -- Ed (Edgar181) 14:19, 6 October 2015 (UTC)[reply]

[[File:Clobetasol propionate.svg|thumb|center|500px|Clobetasol propionate: {{Cite patent|DE|1902340}}]]

Black box warning?

I’m having trouble removing the erroneous black box warning: The side table indicates a black box warning, and there’s also a citation (2) indicating the same. Could somebody please help?

However, there is NOT a black box for this drug in the US. See the FDA monograph. Also, Drugs.com is not a monograph. They copy and past SOME segments and not all portions. They also change the order of information and data. Gobucks821 (talk) 16:57, 3 August 2024 (UTC)[reply]